Details

Autor(en) / Beteiligte

• Cabrera‐Mendoza, Brenda
• Stertz, Laura
• Najera, Katherine
• Selvaraj, Sudhakar
• Teixeira, Antonio L.
• Meyer, Thomas D.
• Fries, Gabriel R.
• Walss‐Bass, Consuelo

Titel

Within subject cross‐tissue analyzes of epigenetic clocks in substance use disorder postmortem brain and blood

Ist Teil von

• American journal of medical genetics. Part B, Neuropsychiatric genetics, 2023-01, Vol.192 (1-2), p.13-27

Ort / Verlag

Hoboken, USA: John Wiley & Sons, Inc

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• There is a possible accelerated biological aging in patients with substance use disorders (SUD). The evaluation of epigenetic clocks, which are accurate estimators of biological aging based on DNA methylation changes, has been limited to blood tissue in patients with SUD. Consequently, the impact of biological aging in the brain of individuals with SUD remains unknown. In this study, we evaluated multiple epigenetic clocks (DNAmAge, DNAmAgeHannum, DNAmAgeSkinBlood, DNAmPhenoAge, DNAmGrimAge, and DNAmTL) in individuals with SUD (n = 42), including alcohol (n = 10), opioid (n = 19), and stimulant use disorder (n = 13), and controls (n = 10) in postmortem brain (prefrontal cortex) and blood tissue obtained from the same individuals. We found a higher DNAmPhenoAge (β = 0.191, p‐value = 0.0104) and a nominally lower DNAmTL (β = −0.149, p‐value = 0.0603) in blood from individuals with SUD compared to controls. SUD subgroup analysis showed a nominally lower brain DNAmTL in subjects with alcohol use disorder, compared to stimulant use disorder and controls (β = 0.0150, p‐value = 0.087). Cross‐tissue analyzes indicated a lower blood DNAmTL and a higher blood DNAmAge compared to their respective brain values in the SUD group. This study highlights the relevance of tissue specificity in biological aging studies and suggests that peripheral measures of epigenetic clocks in SUD may depend on the specific type of drug used.